Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2019-03-27

FDA Approved: EZALLOR SPRINKLE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for EZALLOR SPRINKLE (rosuvastatin) by Sun Pharmaceutical Industries, Inc., related to this rosuvastatin sprinkle fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EZALLOR SPRINKLE (ROSUVASTATIN)

Snippet

SUPPL AP for EZALLOR SPRINKLE (ROSUVASTATIN)